title: [The efficacy of prophylactic antibiotic and tocolytic therapy for premature rupture of the membranes--a prospective randomized study].
abstract: A comparative study in patients with premature rupture of the membranes (PROM) from 25 to 34 weeks of gestation was carried out, prospectively. Group 1 (34 patients) was given aggressively intrauterine therapy including the administration of tocolytic agents (ritodrine and/or magnesium sulfate) and prophylactic antibiotics (AB-PC 2g/day). Group 2 (41 patients) was managed conservatively with bed rest only. At the time of admission to the study, there were no clinical signs of infection, fetal distress, or active labor in either group. All patients were delivered if the pregnancy had reached 35 weeks of gestation or later, had established labor, or developed evidence of chorioamnionitis or fetal distress. Prolongation for more than 72 hours was greater in group 1 than in group 2. There was no difference in the incidence of chorioamnionitis, postpartum endometritis, or placental infection in the groups. However, the incidence of a low Apgar score (7 < at 5 min), requiring artificial ventilation, and infection was more common in group 1. It is concluded that the use of antibiotics and tocolytics might make the management of PROM more complicated.
authors.affiliation: Department of Obstetrics and Gynecology, Kagoshima Municipal Hospital.
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuda
authors.forename: T
authors.initials: T
authors.lastname: Ikenoue
authors.forename: S
authors.initials: S
authors.lastname: Ibara
authors.forename: H
authors.initials: H
authors.lastname: Sameshima
authors.forename: K
authors.initials: K
authors.lastname: Kuraya
authors.forename: H
authors.initials: H
authors.lastname: Hokanishi
mesh_terms: D000900:Anti-Bacterial Agents; D002821:Chorioamnionitis / Q000517:prevention & control; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000008:administration & dosage; D011247:Pregnancy; D011292:Premedication; D011446:Prospective Studies; D012312:Ritodrine / Q000008:administration & dosage
chemical_list: D000900:Anti-Bacterial Agents; D008278:Magnesium Sulfate; D012312:Ritodrine